Ugur Topal | Biophysics | Best Researcher Award

Global Physics Awards

Ugur Topal

Cukurova University, Turkey

Ugur Topal
Affiliation Cukurova University
Country Turkey
Scopus ID 57204197737
Documents 92
Citations 391
h-index 10
Subject Area Biophysics
Event Global Physics Awards
ORCID 0000-0003-1305-2056

Ugur Topal is identified in the supplied profile as a researcher affiliated with Cukurova University in Turkey, with biophysics listed as the subject area. The profile reports 92 documents, 391 citations, and an h-index of 10. This article summarizes the provided bibliographic information and discusses the interpretation of scholarly metrics in the context of the Global Physics Awards. The figures should be checked against the current Scopus author record, as bibliographic databases can change over time. The profile does not independently establish nomination, selection, or receipt of an award.[1][2]

Abstract

This article presents a bibliographic overview of Ugur Topal, identified in the supplied profile as affiliated with Cukurova University in Turkey and associated with biophysics. The profile reports 92 documents, 391 citations, and an h-index of 10, together with ORCID and Scopus author identifiers. These indicators provide a descriptive snapshot of recorded scholarly output and citation activity. The article outlines the relevance of biophysics, discusses publication records and research impact assessment, and considers the profile’s relevance to the Global Physics Awards.[1][2]

Keywords

Ugur Topal; Cukurova University; Turkey; biophysics; physics research; scholarly publications; citation analysis; h-index; Scopus author profile; ORCID; research evaluation; Global Physics Awards.

Introduction

Biophysics applies principles and methods from physics to the study of biological systems, examining processes at molecular, cellular, and larger scales. Its interdisciplinary approach supports quantitative investigations of biological structures, interactions, and dynamics. Research profiles help readers locate scholarly outputs and review publication activity, although database coverage and author attribution may vary. The ORCID and Scopus links supplied for Ugur Topal provide starting points for examining the available bibliographic record and checking the identity associated with the listed metrics.[1][2]

Research Profile

The supplied profile identifies Ugur Topal with Cukurova University in Turkey and lists biophysics as the subject area. It reports 92 documents, 391 citations, and an h-index of 10. These figures are supplied profile data and have not been independently verified for this article. A complete assessment would require reviewing indexed publications, checking affiliations, distinguishing duplicate or incorrectly attributed records, and confirming the date on which the metrics were retrieved. ORCID provides a persistent researcher identifier that can help distinguish researchers with similar names and connect their scholarly activities.[1][2]

Research Contributions

Biophysics encompasses quantitative approaches to understanding biological phenomena, including molecular interactions, structural organization, transport, and the physical principles governing living systems. The specific contributions of an individual researcher must be established from verified publications rather than inferred from a subject classification or citation count. For Ugur Topal, an evidence-based account should identify research questions, methods, findings, and collaborations through confirmed publications. No particular discovery, methodology, or scientific breakthrough is attributed here without supporting publication-level evidence.[3]

Publications

The supplied profile reports 92 documents associated with the researcher. This figure should be checked against the current Scopus author record because indexed totals may change when publications are added, corrected, or reassigned. A reliable publication overview would include verified article titles, co-authors, journal or conference details, publication years, and DOI identifiers where available. Individual bibliographic records were not provided for this article, so specific paper titles and DOI numbers are not asserted. Readers can consult the linked author profile to examine the indexed record directly.[1]

Research Impact

The supplied metrics of 391 citations and an h-index of 10 describe aspects of recorded scholarly attention and publication activity. An h-index of 10 conventionally indicates at least ten publications with at least ten citations each within the database and records used for its calculation. Citation counts can vary between platforms, while research field, career stage, co-authorship, and publication type affect comparisons. These values should therefore be treated as descriptive indicators rather than conclusive measures of originality or research quality. A transparent evaluation combines bibliometric information with expert assessment of the underlying work.[3][4]

Award Suitability

The Global Physics Awards provides the event context for this research profile. The supplied information offers a basis for organizing a preliminary bibliographic summary, but it does not establish that Ugur Topal has been nominated, shortlisted, selected, or confirmed as a recipient. Any award assessment should follow the event’s published eligibility requirements and evaluation procedures, considering verified publications, documented research contributions, originality, and relevant professional achievements..[3][4]

Conclusion

The supplied information identifies Ugur Topal as a researcher affiliated with Cukurova University in Turkey, with biophysics listed as the subject area. The reported totals of 92 documents, 391 citations, and an h-index of 10 provide a starting point for reviewing the research profile. These figures require confirmation against current bibliographic records and should be interpreted in context.

References

    1. Elsevier. (2026.). Scopus author details: Ugur Topal, Author ID 57204197737. Scopus.
      https://www.scopus.com/authid/detail.uri?authorId=57204197737
    2. ORCID. (2026.). ORCID researcher identifier: Ugur Topal.
      https://orcid.org/0000-0003-1305-2056
    3. Peritoneal Metastasis as a Distinct Biological Entity: Mechanisms, Microenvironment, and Therapeutic Implications.
      https://www.mdpi.com/2673-8937/6/3/27
    4. Global Physics Awards. (2026.). Official award website.
      https://globalphysicsawards.com/

Arti Goel | Biophysics | Innovative Research Award

Global Physics Awards

Researcher: Arti Goel
Institution: Amity University, Noida, India

Arti Goel
Affiliation Amity University, Noida, India
Country India
Scopus ID 56995595000
Documents 29
Citations 223
h-index 9
Subject Area Biophysics
Event Global Physics Awards
ORCID 0000-0002-5274-6029

This academic profile summarizes publicly available scholarly information relating to Arti Goel, a researcher affiliated with Amity University, Noida, India. The page is presented in a neutral encyclopedic format to provide an overview of research activity, publication metrics, scholarly impact, and relevance to the Global Physics Awards. Information presented herein is based on publicly accessible scholarly records and persistent researcher identifiers where available.[1]

Abstract

Arti Goel’s scholarly activities are situated within the interdisciplinary domain of biophysics, where physical principles are applied to biological systems. Her documented publication record, citation metrics, and international researcher identifiers indicate sustained participation in scientific research and scholarly communication.[1][2]

Keywords

Biophysics, Scientific Research, Scopus, Citation Analysis, Academic Publications, Scholarly Impact, Research Metrics, Global Physics Awards, ORCID, Interdisciplinary Science.

Introduction

Biophysics integrates methods from physics, biology, chemistry, and computational science to investigate complex biological phenomena. Researchers in this discipline contribute to improved scientific understanding through experimental, analytical, and interdisciplinary approaches.[1][2]

Research Profile

According to publicly available bibliometric information, Arti Goel is affiliated with Amity University, Noida, India. The researcher is indexed in Scopus under Author ID 56995595000 and has an established publication record comprising 29 indexed documents, 223 citations, and an h-index of 9. These indicators represent measurable aspects of publication activity and scholarly influence within indexed literature.[1]

Research Contributions

The available publication portfolio demonstrates continued engagement with interdisciplinary scientific research relevant to biophysics. Contributions include participation in peer-reviewed scientific communication, collaborative research, and dissemination of findings through recognized academic channels.[3]

Publications

The Scopus profile records twenty-nine indexed publications associated with the researcher. These publications collectively contribute to citation accumulation and measurable research visibility. Persistent identifiers such as DOI facilitate permanent access to published scientific literature and improve reproducibility and citation tracking.[1][3]

Research Impact

Bibliometric indicators including citation count and h-index are commonly used to evaluate patterns of scholarly influence, although they represent only one dimension of research assessment. The available metrics indicate that Arti Goel’s publications have received citations within the indexed scientific literature, reflecting continued engagement by the research community.[1]

Award Suitability

Based on publicly available scholarly information, the documented research profile demonstrates sustained academic activity, peer-reviewed publication, measurable citation performance, and internationally recognized researcher identifiers. Such characteristics are generally relevant when evaluating researchers for academic recognition programs, while any formal award determination remains subject to the independent criteria, review process, and policies established by the organizers of the Global Physics Awards.[4]

Conclusion

The available bibliometric evidence presents Arti Goel as an active researcher within the field of biophysics with documented scholarly output indexed by recognized academic databases. Persistent identifiers, publication metrics, and citation records collectively support transparent academic documentation while providing an objective overview of research activity suitable for informational and reference purposes.[1]

References

  1. Elsevier (2026). Scopus author details: Arti Goel, Author ID 56995595000. Scopus.
    https://www.scopus.com/pages/authors/56995595000
  2. ORCID (2026). ORCID record for Arti Goel.
    https://orcid.org/0000-0002-5274-6029
  3. Ramification of mycogenic copper oxide nanoparticles on wastewater remediation from selected sites of Yamuna River.
    https://link.springer.com/article/10.1007/s10653-025-02769-2
  4. Global Physics Awards (2026). Official Award Website.
    https://globalphysicsawards.com/

Bernard Mouillac | Biophysics | Best Researcher Award | 4493

Dr. Bernard Mouillac | Biophysics | Best Researcher Award

Dr. Bernard Mouillac, Institute of Functional Genomics, France

Dr. Bernard Mouillac, PhD, is a distinguished French molecular pharmacologist with extensive expertise in cell biology, structural pharmacology, and G protein-coupled receptors (GPCRs). Currently serving as Team Co-leader and Research Director (DR2) at INSERM, he has led pioneering work at the Institut de Génomique Fonctionnelle in Montpellier since 1998. His career includes a postdoctoral fellowship under Prof. Michel Bouvier in Canada and over three decades of contributions to receptor biology. Dr. Mouillac’s research, published in leading journals such as Science Advances and Nature, has significantly advanced the structural understanding of hormone-receptor interactions. He is co-author of 128 publications (H-index: 45, >8,500 citations) and holds four patents. An esteemed reviewer and committee member, his leadership spans European research projects and global GPCR initiatives.

Author Profile

Orcid

🎓 Early Academic Pursuits: A Foundation of Excellence

Dr. Mouillac’s academic journey began at the University of Montpellier, where he earned a Master’s degree (1986) and a Ph.D. (1990) in Biochemistry, Molecular and Cellular Biology. His foundational studies equipped him with critical skills in cellular signaling, protein interactions, and biochemical pathways, setting the stage for an outstanding scientific career. His academic brilliance was further solidified during his postdoctoral fellowship (1991–1992) at the University of Montreal, Canada, under the mentorship of the globally renowned Prof. Michel Bouvier. This early exposure to receptor biology and pharmacological modeling shaped the direction of his life’s research.

🧪 Professional Endeavors and Research Contributions

Dr. Mouillac has held progressively impactful roles in the French biomedical research ecosystem:

  • 1993–1998: Associate Researcher at CNRS-INSERM Centre for Pharmacology-Endocrinology, Montpellier.

  • 1998–Present: Team Leader at the Institut de Génomique Fonctionnelle, where he has advanced as a pivotal contributor in GPCR-related research.

His research focus is centered on G protein-coupled receptors, particularly vasopressin and oxytocin receptors, which are crucial in numerous physiological processes. Through cutting-edge structural biology techniques, including cryo-electron microscopy and time-resolved FRET, he has deciphered the mechanisms of receptor-ligand interactions and biased signaling.

His co-authored paper in Science Advances (2022) describing the vasopressin hormone-V2 receptor-β-arrestin1 ternary complex is one of the landmark studies in the field, providing unprecedented insights into receptor conformation and signaling fidelity. Overall, he has authored 128 scientific articles, with an H-index of 45 and 8,565+ citations, illustrating both the quantity and quality of his research.

🏆 Accolades and Recognition

Dr. Mouillac’s excellence has been consistently recognized through numerous prestigious awards and funding:

  • Prix des Laboratoires Logeais (1993)

  • INSERM Prize for Scientific Excellence (2012–2015 and 2024–2027)

  • Principal investigator in multiple ANR projects (RIB, Neurosciences, Blanc Architect, StrainV2)

  • European project involvement under STREP 6th PCRDT

He has also been awarded significant grants from the Fondation pour la Recherche Médicale (FRM), including an engineer grant (2014–2016) and team support (2015–2018).

🌍 Impact and Influence: A Global Scientific Voice

Dr. Mouillac is not only a researcher but also a global voice in pharmacological science. His ad hoc reviewer roles for elite journals such as Nature, PNAS, Nature Structural & Molecular Biology, and JBC signify the trust the global community places in his judgment and expertise. He has evaluated grants for prominent institutions including ANR (France), Wellcome Trust (UK), AIRC (Italy), and Austrian Science Fund, showcasing his international influence.

He also chaired the IUPHAR Subcommittee on Vasopressin/Oxytocin Receptors (2004–2017), helping shape international classification and nomenclature systems for GPCRs.

🤝 Leadership and Collaboration in Research

Dr. Mouillac has long been a catalyst for collaborative science. He co-organized leading scientific events such as:

  • “A Day in the Life of G Protein-Coupled Receptors” (2004, Montpellier)

  • 3rd GPCR International Annual Meeting (2014, Montpellier)

His collaborations with structural biologists like Dr. Sébastien Granier and electron microscopy experts have enriched interdisciplinary approaches and led to co-corresponding author roles in several high-impact publications. His patents (including WO 2004/113539A3 and EP 2014 2708235A1) also show his aptitude in translational innovation.

🚀 Legacy and Future Contributions

With more than 30 years at the forefront of GPCR pharmacology, Dr. Bernard Mouillac has already left a considerable legacy. Yet, he continues to push boundaries with current projects like ANR V2Cure (2023–2026) and ANR OT-ism (2024–2027). His mentorship of emerging scientists, leadership in INSERM’s CSS1 committee, and pioneering experimental designs ensure that the next generation of biomedical researchers will stand on solid shoulders.

✍️ Publication Top Notes


📘 Inactive structures of the vasopressin V2 receptor reveal distinct binding modes for Tolvaptan and Mambaquaretin toxin

Author:  Bernard MOUILLAC
Journal: Nature Communications
Year: 2025

📘 G protein peptidomimetics reveal allosteric effects and stepwise interactions in ghrelin receptor–G protein coupling
Author: Morgane Mannes; Charlotte Martin; Marjorie Damian; Sonia Cantel; Hélène Orcel; Jean-Alain Fehrentz; Bernard Mouillac; Julie Kniazeff; Jean-Louis Banères; Steven Ballet

Journal: Science Signaling

Year: 2025

📘 Structures of the arginine-vasopressin and oxytocin receptor signaling complexes

Author: Julien Bous; Aurélien Fouillen; Hélène Orcel; Sébastien Granier; Patrick Bron; Bernard Mouillac
Journal: Vitamins and Hormones
Year: 2023

Maraf mbah bake | Computational Biophysics | Best Researcher Award 

Mr. Maraf mbah bake | Computational Biophysics | Best Researcher Award 

University of Texas at El Paso | United States 

AUTHOR PROFILE

EARLY ACADEMIC PURSUITS

MBAH BAKE Maraf's academic journey began with his Bachelor of Science Degree (B.Sc.) in Chemistry from the Department of Inorganic Chemistry at the Faculty of Sciences, University of Dschang, Cameroon. He then pursued a Master's Degree in Chemistry with a specialization in Theoretical and Physical Chemistry from the Inorganic Chemistry Department at the same institution. Subsequently, he ventured into teaching as a Chemistry Teacher at Government Bilingual High School Pouma, Cameroon, before advancing his academic pursuits with a Master of Science in Computational Chemistry at the Inorganic Chemistry Department, Faculty of Sciences, University of Yaoundé I, Cameroon.

PROFESSIONAL ENDEAVORS

MBAH BAKE Maraf's professional journey encompasses a diverse range of roles, from teaching Chemistry at the high school level to conducting research in computational chemistry at prestigious institutions such as the University of Texas at El Paso (UTEP). Currently, he serves as a Graduate Student and Teaching Assistant in Physics at UTEP, where he is involved in a project titled "Design of Anti-Cancer Drug Targeting Kinesin Protein, Quantum Computing, and Machine Learning Analysis" under the supervision of Prof. Lin Li.

CONTRIBUTIONS AND RESEARCH FOCUS

MBAH BAKE Maraf's research focuses primarily on Computational Biophysics, with a specific interest in understanding molecular mechanisms underlying various biological processes and designing potential therapeutic agents. His expertise lies in quantum chemistry, screening, molecular dynamics analysis, and modeling chemical reactivity and properties using computational tools. Through his research endeavors, he aims to contribute to the development of novel drugs for diseases such as malaria, HIV, cancer, and hepatitis B virus.

IMPACT AND INFLUENCE

MBAH BAKE Maraf's research outputs, including scientific publications and participation in conferences and workshops, reflect his significant contributions to the field of Computational Biophysics. His work has been recognized internationally, and he serves as a reviewer for the International Journal of Quantum Chemistry, reflecting his expertise and influence in the academic community.

ACADEMIC CITES

MBAH BAKE Maraf's research publications in reputable journals demonstrate the impact of his work in Computational Biophysics. His contributions to understanding molecular reactions and designing potential therapeutic agents have garnered attention within the scientific community, further solidifying his reputation as a leading researcher in the field.

LEGACY AND FUTURE CONTRIBUTIONS

As MBAH BAKE Maraf continues his academic and research endeavors in Computational Biophysics, his legacy is poised to make a significant impact on the field. Through his innovative research projects and collaborations with renowned scientists, he aims to advance our understanding of complex biological processes and contribute to the development of novel therapeutics. His future contributions hold the promise of addressing critical healthcare challenges and improving patient outcomes through computational approaches.

NOTABLE PUBLICATION